Research map: Governing molecular tumor boards: Precision funnel analysis, outcome gap, and a pay-at-result reform framework — Evidence from a nationally mandated programme

Back to the article

Papers in this map

  1. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer · Jennifer S. Temel · 2010 · 7563 citations · Cited by this paper
  2. The hidden giant: Why head and neck cancer represents a strategic priority for cancer policy in Brazil · 2026 · Related
  3. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial · Camilla Zimmermann · 2014 · 1832 citations · Cited by this paper
  4. Coastal cancer care: A blueprint to address the unmet needs through place-based research and policy approaches · 2026 · Related
  5. The Danish Cancer Registry · Marianne L. Gjerstorff · 2011 · 1370 citations · Cited by this paper
  6. Integrating early cancer care into one pathway: Comparison across Denmark, the Netherlands and Italy · 2026 · Related
  7. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) · Joaquı́n Mateo · 2018 · 833 citations · Cited by this paper
  8. Establishing a national shared care network for paediatric oncology in Cameroon: Development process, baseline findings and early lessons · 2026 · Related
  9. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature · Brindha Pillay · 2015 · 721 citations · Cited by this paper
  10. Beyond rurality: Regional and service-system variation in cancer patient experience in Scotland · 2026 · Related
  11. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials · Funda Meric‐Bernstam · 2015 · 436 citations · Cited by this paper
  12. Europe’s oncology industrial complex: size, components, and implications for value · 2026 · Related
  13. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group · Maria Fernanda Mosele · 2024 · 409 citations · Cited by this paper
  14. Country-Level Right-to-Health and Health-System Indicators and Five-Year Net Survival from Adult Brain Tumours: An Ecological Analysis Using CONCORD-3 Data · 2026 · Related
  15. Delivering precision oncology to patients with cancer · Joaquı́n Mateo · 2022 · 381 citations · Cited by this paper
  16. Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys · 2026 · Related
  17. Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) · Keith T. Flaherty · 2020 · 303 citations · Cited by this paper
  18. Integrating trauma-informed and culturally grounded perspectives into refugee cancer prevention · 2026 · Related
  19. Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers · Peter Horak · 2021 · 298 citations · Cited by this paper
  20. Toward an inclusive cancer clinical trial model: Health system geography and lessons from Australia for Saudi Arabia · 2026 · Related
  21. Toward a Consensus on Centralization in Surgery · René Vonlanthen · 2018 · 271 citations · Cited by this paper
  22. Tumor Evolution as a Therapeutic Target · Nabil Amirouchene-Angelozzi · 2017 · 207 citations · Cited by this paper
  23. Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund · Ajay Kumar Aggarwal · 2017 · 167 citations · Cited by this paper
  24. Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta‐Analysis · Dong Peng · 2021 · 74 citations · Cited by this paper
  25. Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial · Paolo Marchetti · 2025 · 37 citations · Cited by this paper
  26. Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience · Matteo Repetto · 2023 · 29 citations · Cited by this paper
  27. Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps · Beryl Primrose Gladstone · 2025 · 29 citations · Cited by this paper
  28. The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world · Patrizio Giacomini · 2023 · 17 citations · Cited by this paper
  29. Patient attrition in Molecular Tumour Boards: a systematic review · Hannah Frost · 2022 · 16 citations · Cited by this paper
  30. An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund · Laura A. Trigg · 2023 · 7 citations · Cited by this paper
  31. Real-World Outcomes of Molecular Tumor Board Treatment Recommendations · Federico Nichetti · 2025 · 7 citations · Cited by this paper
  32. The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy · Veronica Agostinelli · 2025 · 3 citations · Cited by this paper
  33. OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework · Virginie Crespel · 2024 · 2 citations · Cited by this paper
  34. Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression · Giovanni Maria Iannantuono · 2026 · 2 citations · Cited by this paper
  35. Untitled · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)